A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.
Clinical trial NCT06731075 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06731075
- Sponsor
- Oramed, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2027-04-25
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.